Drug recall · March 10, 2021
Famotidine Tablets USP 40mg recall
Why: Presence of foreign tablets/capsules: Famotidine 20mg and ibuprofen 400mg tablets were found in a lot of famotidine 40mg.
Class II: could cause temporary or reversible health problems; serious harm is remote.
The recall
- Product
Famotidine Tablets USP 40mg, 1,000-count bottles, Rx only, Distributed by: Aurobindo Pharma USA, Inc. 279 Princeton-Hightstown Road East Windsor, NJ 08520 Made in India, NDC 65862-860-99
- Lots / codes
Lot #: P2000467, Exp 7/2022
- Quantity
- 1296 bottles
- Company
- Aurobindo Pharma USA Inc., East Windsor, NJ
- Distribution
- TX, CA, GA, PA
- Initiated
- January 20, 2021 · Voluntary: Firm initiated
- Classified
- February 26, 2021
- Reported
- March 10, 2021
- Ended
- October 12, 2023
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Famotidine
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.